The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

@article{Cavaletti2013TheCP,
  title={The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.},
  author={Guido Cavaletti and David Reid Cornblath and Ingemar S. J. Merkies and Tjeerd J. Postma and Emanuela Rossi and Barbara Frigeni and Paola Alberti and Jordi Bruna and Roser Velasco and Andreas A. Argyriou and Haralambos P. Kalofonos and Dimitri Psimaras and Damien Ricard and Andrea Pace and Edvina Gali{\`e} and C Briani and Chiara Dalla Torre and Catharina G. Faber and Roy I. Lalisang and Willem Boogerd and Dieta Brandsma and Susanne Koeppen and Joerg Hense and David Storey and Simon Kerrigan and Angelo Schenone and Sabrina Fabbri and Maria Grazia Valsecchi},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2013},
  volume={24 2},
  pages={454-62}
}
BACKGROUND Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and dose-limiting complication of cancer treatment. Thus far, the impact of CIPN has not been studied in a systematic clinimetric manner. The objective of the study was to select outcome measures for CIPN evaluation and to establish their validity and reproducibility in a cross-sectional multicenter study. PATIENTS AND METHODS After literature review and a consensus meeting among experts, face/content validity were… CONTINUE READING
62 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 62 extracted citations

Similar Papers

Loading similar papers…